AngioSoma, Inc. Starts SOMA Nutraceuticals, Inc.’s Operations

Houston, TX — (ReleaseWire) — 04/26/2017 — AngioSoma, Inc., (OTCMKTS:SOAN) recently filed its 10K for the period ending September 30, 2016 and its 10Q for the period ending December 31, 2016. AngioSoma, Inc.’s management would like to update its shareholders on recent progress within its 2017 business plan, including starting operations at its SOMA Nutraceuticals, Inc. Read more about AngioSoma, Inc. Starts SOMA Nutraceuticals, Inc.’s Operations[…]

November 2016 Shareholder Presentation

With so many changes at AngioSoma, Inc. over the last month, we wanted to update our September 2016 shareholder presentation to correctly reflect what AngioSoma, Inc. has been doing.  We have made the November 2016 AngioSoma, Inc. Shareholder Presentation available in both the PDF version and embedded here in its Microsoft PowerPoint version:   © 2016 by Read more about November 2016 Shareholder Presentation[…]

AngioSoma, Inc. Acquires Patented Nutraceutical for Muscle Mass Development

MONTGOMERY, Texas — (BUSINESS WIRE, November 17, 2016 09:45 AM Eastern Standard Time) — AngioSoma, Inc. (OTCQB: SOAN) announces that its new subsidiary Soma Nutraceuticals, Inc. is the recipient of intellectual property conveyed by its Chairman Emeritus Dr. David Summers, including a nutraceutical product using either natural or synthetic nicotine in a patented method for Read more about AngioSoma, Inc. Acquires Patented Nutraceutical for Muscle Mass Development[…]